References

Basra RK, Wagg A, Chapple C A review of adherence to drug therapy in patients with overactive bladder. BJU Int. 2008; 102:(7)774-9 https://doi.org/10.1111/j.1464-410X.2008.07769.x

Fox C., Smith T, Maidment I Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014; 43:(5)604-15 https://doi.org/10.1093/ageing/afu096

Haylen BT, Maher CF, Barber MD An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016; 27:(2)65-194 https://doi.org/10.1007/s00192-016-3003-y

Lamers BH, Broekman BM, Milani AL. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J. 2011; 22:(6)637-44 https://doi.org/10.1007/s00192-011-1390-7

Milsom I, Gyhagen M. The prevalence of urinary incontinence. Climacteric. 2019; 22:(3)217-22 https://doi.org/10.1080/13697137.2018.1543263

National Institute for Health and Care Excellence. Urinary incontinence: the management of urinary incontinence in women. 2006. https://www.nice.org.uk/guidance/cg40 (accessed 5 June 2019)

National Institute for Health and Care Excellence. Urinary incontinence in women: management. 2013. https://www.nice.org.uk/guidance/cg171 (accessed 5 June 2019)

National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. 2015. https://www.nice.org.uk/guidance/cg174 (accessed 5 June 2019)

National Institute for Health and Care Excellence. Menopause: diagnosis and management. 2015. https://www.nice.org.uk/guidance/ng23 (accessed 5 June 2019)

National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. 2017. https://www.nice.org.uk/guidance/ng12 (accessed 26 June 2019)

National Institute for Health and Care Excellence. Urinary tract infection (lower): antimicrobial prescribing. 2018. https://www.nice.org.uk/guidance/ng109 (accessed 26 June 2019)

National Institute for Health and Care Excellence. Urinary incontinence and pelvic organ prolapse. 2019. https://www.nice.org.uk/guidance/ng123 (accessed 5 June 2019)

Palma F, Volpe A, Villa P, Cagnacci A. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study. Maturitas. 2016; 83:40-4 https://doi.org/10.1016/j.maturitas.2015.09.001

Ryan B. Squeezy app. Nursing Standard. 2014; 28:(30)

Smith FJ, Holman CAJ, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010; 116:(5)1096-1100 https://doi.org/10.1097/AOG.0b013e3181f73729

Sousa MS, Peate M, Jarvis S, Hickey M, Friedlander M. A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Ther Adv Med Oncol. 2017; 9:(4)269-85 https://doi.org/10.1177/1758834016687260

Women’s health

Urinary incontinence and pelvic organ prolapse in primary care

02 July 2019
Clinical
02 July 2019
Volume 30 · Issue 7

Abstract

The National Institute for Health and Care Excellence has released an updated guideline on urinary incontinence and pelvic organ prolapse. Angie Rantell explores the changes and recommendations for patients, highlighting which are relevant to management in primary care

In 2019, the National Institute for Health and Care Excellence published a new guideline on urinary incontinence and pelvic organ prolapse. This articles provides an overview of the changes to the recommendations relevant to the primary care setting, mainly related to assessment and conservative management, along with a review of when to refer into specialist services. A brief overview of the changes it has made in secondary care will also be discussed.

Urinary incontinence (UI) is thought to affect up to 70% of women at some point in their life (Milsom, 2019). According to Smith et al (2010), 50% of parous women will develop a pelvic organ prolapse (POP) in their lifetime. The prevalence for both of these problems increases with age and represents a significant problem in healthcare as the population ages.

The National Institute for Health and Care Excellence (NICE) (2006; 2013) guidelines have previously made practice recommendations for the management of female UI in primary and secondary care; however, there has never been a guideline related to POP. Given that a significant number of women will experience either UI, POP or both in their lifetime, NG123 was published in April 2019 (NICE, 2019) to not only update the UI guidelines, but to also provide the first ever guidance on the assessment and management of POP.

Register now to continue reading

Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month

Register
Or continue by

Signing in with your registered email address

Pelvic organ prolapse
Urinary incontinence
NICE guidelines
Primary care